In Vitro Activities of Garenoxacin (BMS 284756) against 108 Clinical Isolates of Gardnerella vaginalis
2002 ◽
Vol 46
(12)
◽
pp. 3995-3996
◽
Keyword(s):
ABSTRACT Garenoxacin (BMS 284756) was active against 105 of 108 (97%) recent clinical Gardnerella vaginalis isolates at ≤2 μg/ml by using the reference agar dilution method for anaerobes. Twenty-eight percent of isolates (31 of 108) were resistant to metronidazole, and 44% were resistant to doxycycline. All were susceptible to clindamycin and ampicillin-sulbactam.
2002 ◽
Vol 46
(9)
◽
pp. 3068-3070
◽
1996 ◽
Vol 40
(6)
◽
pp. 1419-1421
◽
2003 ◽
Vol 47
(6)
◽
pp. 1968-1971
◽
Keyword(s):
2013 ◽
Vol 59
(4)
◽
pp. 252-259
◽
2007 ◽
Vol 51
(8)
◽
pp. 2716-2719
◽
2006 ◽
Vol 50
(1)
◽
pp. 379-381
◽
Keyword(s):
2001 ◽
Vol 45
(11)
◽
pp. 3205-3208
◽
2006 ◽
Vol 24
(4)
◽
pp. 273-279
2015 ◽
Vol 2015
◽
pp. 1-10
◽
2008 ◽
Vol 3
(9)
◽
pp. 1934578X0800300
◽